发现新的抗氧化分子增强Nrf2-介导途径:对接研究和生物评估
Simona De Vita1, Elena González-Burgos2, Stefania Terracciano1
1Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 134, 84084 Fisciano, SA, Italy.
International journal of molecular sciences
|February 27, 2026
概括
科学家们探索化合物来增强身体的天然抗氧化防御,准Nrf2通道来对抗与神经退行性疾病 (如阿尔茨海默氏症和帕金森氏症) 相关的氧化应激.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 氧化应激与神经退行性疾病有关.
- 激活Nrf2通路是一种潜在的治疗策略.
- 调节Nrf2-Keap1相互作用是关键的.
研究的目的:
- 确定针对Nrf2-Keap1相互作用的新型分子支架.
- 评估神经母细胞瘤细胞系中选定的化合物的抗氧化活性.
主要方法:
- 在in silico对接实验中选分子.
- 在体外抗氧化剂测试中使用芬顿反应.
- 评估活性氧物种 (ROS) 和脂质过氧化.
- 测量GSH/GSSG比率和Nrf2下游蛋白质表达.
主要成果:
- 化合物1-4显示出对抗氧化应激的保护作用.
- 最佳度在5μM (化合物4) 到25μM (化合物2) 之间.
- 化合物降低了ROS,脂质过氧化,并增加了GSH/GSSG的比率,上调了Nrf2-依赖的抗氧化酶.
结论:
- 化合物1-4通过激活Nrf2通路显示出显著的抗氧化潜力.
- 在测试的分子中,化合物3是最强的.
- 这些发现支持Nrf2激活剂作为神经退行性疾病的治疗途径.
相关概念视频
NF-κB-dependent Signaling Pathway
10.1K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
10.1K
Electron Transport Chain: Complex I and II
19.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
19.2K
Drug Discovery: Overview
12.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.3K
Nitric Oxide Signaling Pathway
6.5K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.5K

